One such therapy is the powerful combination of BPC-157 and TB-500 , two peptides renowned for their regenerative and healing properties
The data show that a substantial number of Phase II awards are attracting Phase III funding, although the figure does not make clear the substantial lags involvedPhase II awards are often ripe for Phase III 4 or more years after the award
Sample Weekly Schedule Here is what a typical week looks like on this stack: Monday through Friday: Morning: Topical GHK-Cu applied to face and any target areas after cleansing Any time of day: Injectable GHK-Cu 200 to 600 mcg (if using injectable form) Evening: Optional second topical GHK-Cu application One day per week (your chosen semaglutide day): Semaglutide injection at your usual time (different site from GHK-Cu) Continue GHK-Cu as normal Weekend (if using 5-day injectable schedule): Continue topical GHK-Cu Skip injectable GHK-Cu (some patients prefer a 5 days on, 2 days off schedule for convenience, though daily is also fine) Expanding the Stack Some patients choose to add additional compounds to this foundation
However, research is still ongoing, and we will likely learn a lot more about the benefits of BPC-157 peptides for soft tissue repair
Moreover, EAE is characterized by a CD4 T lymphocytic preponderance in contrast to CD8 T cells in MS lesions (Day, 2005)
